Chemically modified konjac glucomannan with high colloid osmotic pressure: Physiological evaluation in a rabbit model as a plasma substitute

Glycobiology

Volumn 20, Issue 8, 2010, Pages 950-958

  Li, Suping ^a,b   Hu, Tao ^a   Chen, Yali ^a   Wang, Xianwei ^c   Liu, Tao ^a,b   Ma, Guanghui ^a   Su, Zhiguo ^a  

^a National Key Laboratory of Biochemical Engineering   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Carboxylmethylation; Colloid osmotic pressure; Konjac glucomannan; Plasma substitute

Indexed keywords

HETASTARCH; HUMAN SERUM ALBUMIN; MANNAN; PLASMA SUBSTITUTE; POLYGELINE;

AMORPHOPHALLUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HEMATOCRIT; HEMODYNAMICS; HEMORRHAGIC SHOCK; NONHUMAN; ONCOTIC PRESSURE; PRIORITY JOURNAL; RABBIT;

ANIMALS; COLLOIDS; HYDROLYSIS; MALE; MANNANS; MODELS, ANIMAL; OSMOTIC PRESSURE; PLASMA SUBSTITUTES; RABBITS;

AMORPHOPHALLUS KONJAC; ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 77954500224     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq050     Document Type: Article

References (31)

1. Boldt J. 2004. Hydroxyethyl starch: Can the safety problems be ignored? Wien Klin Wochenschr. 116(17-18):640-641.
2. Dalrymple-Hay M, Aitchison R, Collins P, Sekhar M, Colvin B. 1992. Hydroxyethyl starch induced acquired von Willebrand's disease. Clin Lab Haematol. 14(3):209-211.
3. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. SAFE Study investigators. 2004. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 350(22):2247-2256.
4. Frese A, Rinke D, Kunnecke M, Stinner B, Lorenz W, Wesemann W, Opper C. 2000. Platelet aggregation during abdominal surgery in an experimental pig model: The effects of presurgical antibiotic protocols and volume replacement with hydroxyethyl starch. Thromb Res. 97(3):143-151.
5. Grauer MT, Woessner R, Haass A, Treib J. 1999. Volume therapy in patients with acute stroke. Transfus Altern Transfus Med. 1(3):18-24.
6. Hashmi F, Al Ghazzewi, Khanna S, Piggott J. 2007. The potential use of hydrolysed konjac glucomannan as a prebiotic. J Sci Food Agric. 87(9): 1758-1766.
7. He JM, Chen WX, Dong XX. 1990. Polymer Physics. Shanghai: Fudan University Publishers. 155-160.
8. Kreimeier U, Messmer K. 1996. Hemodilution in clinical surgery: State of the art 1996. World J Surg. 20(9):1208-1217.
9. Lundberg JS, Perl TM, Wiblin T, Costigan MD, Dawson J, Nettleman MD, Wenzel RP. 1998. Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med. 26 (6):1020-1024.
10. Macintyre E, Bullen C, Machin SJ. 1985. Fluid replacement in hypovolaemia. Intensive Care Med. 11(5):231-233.
11. Madjdpour C, Dettori N, Frascarolo P, Burki M, Boll M, Fisch A, Bombeli T, Spahn DR. 2005. Molecular weight of hydroxyethyl starch: Is there an effect on blood coagulation and pharmacokinetics? Br J Anaesth. 94(5):569-576.
12. Maeda M, Shimahara H, Sugiyamsa N. 1980. Detailed examination of the branched structure of konjac glucomnnan. Agric Biol Chem. 44(2):245-252.
13. Messmer KFW. 1987. The use of plasma substitutes with special attention to their side effects. World J Surg. 11(1):69-74.
14. Nanae HH, Nacharaju P, Manjula BN, Cabrales P, Tsai AG, Acharya SA, Intaglietta M. 2006. Microvascular effects following treatment with polyethylene glycol-albumin in lipopolysaccharide-induced endotoxemia. Crit Care Med. 34(1):108-117.
15. Nascimento P Jr., de Paiva Filho O, de Carvalho LR, Braz JRC. 2006. Early hemodynamic and renal effects of hemorrhagic shock resuscitation with lactated ringer's solution, hydroxyethyl starch and hypertonic saline with or without 6% dextran-70. J Surg Res. 136(1):98-105.
16. Nolan J. 2001. Fluid resuscitation for the trauma patient. Resuscitation. 48(1): 57-69.
17. Persson J, Grande PO. 2005. Volume expansion of albumin, gelatin, hydroxyethyl starch, saline and erythrocytes after haemorrhage in the rat. Intensive Care Med. 31(2):296-301.
18. Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT, Kaufman BS, Putnam D. 1983. Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med. 11(11):839-850.
19. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. 2001. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 345(19):1368-1377.
20. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. 2001. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis. A multicentre randomised study. Lancet. 357(9260):911-916.
21. Shimahara H, Suzuki H, Sugiyama N, Nisizawa K. 1975. Isolation and characterization of oligosaccharides from an enzymic hydrolysate of konjac glucomannan. Agric Biol Chem. 39(2):293-299.
22. Stump D, Strauss R, Henriksen R, Petersen R, Saunders R. 1985. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion. 25(4):349-354.
23. Takahashi R, Kusakabe I, Kusama S. 1984. Structures of glucomanno-oligosaccharides from the hydrolytic products of konjac glucomannan produced by a β-mannanase from Streptomyces sp. Agric Biol Chem. 48(12):2943-2950.
24. ten Dam MA, Branten AJ, Klasen IS, Wetzels JF. 2001. The gelatin-derived plasma substitute gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption. J Crit Care. 16(3):115-120.
25. Tonnessen T, Tollofsrud S, Kongsgaard UE, Noddeland H. 1993. Colloid osmotic pressure of plasma replacement fluids. Acta Anaesthesiol Scand. 37(4):424-426.
26. Treib J, Baron JF, Grauer MT, Strauss RG. 1999. An international view of hydroxyethyl starches. Intensive Care Med. 25(3):258-268.
27. Tsuda Y, Hartmann A, Weiand J, Solymosi L. 1987. Comparison of the effects of infusion with hydroxyethyl starch and low molecular weight dextran on cerebral blood flow and hemorheology in normal baboons. J Neurol Sci. 82 (1-3):171-180.
28. Vandegriff KD, McCarthy M, Rohlfs RJ, Winslow RM. 1997. Colloid osmotic properties of modified hemoglobins: Chemically cross-linked versus polyethylene glycol surface-conjugated. Biophys Chem. 69(1):23-30.
29. Wettstein R, Tsai AG, Erni D, Lukyanov AN, Torchilin VP, Intaglietta M. 2004. Improving microcirculation is more effective than substitution of red blood cells to correct metabolic disorder in experimental hemorrhagic shock. Shock. 21(3):235-240.
30. Yao WJ, Wen ZY, Yan ZY, Sun DG, Ka WB, Xie LD, Chien S. 2001. Low viscosity ektacytometry and its validation tested by flow chamber. J Biomech. 34(11):1501-1509.
31. Zornow MH, Scheller MS, Todd MM, Moore SS. 1988. Acute cerebral effects of isotonic crystalloid and colloid solutions following cryogenic brain injury in the rabbit. Anesthesiology. 69(2):180-184.